Spyre Therapeutics, Inc. · NASDAQ:SYRE

Burrows Scott L sold 7,500 Spyre Therapeutics, Inc. shares (Form 4)

Traded Aug 3, 2026 · Filed Aug 5, 2026

On Aug 3, 2026, Burrows Scott L (Chief Financial Officer) sold 7,500 Spyre Therapeutics, Inc. shares at an average US$95.57 for US$717K under a trading plan, leaving 97,994 shares. Filed Aug 5, 2026 (Form 4).

Sold: 7,500 shares
Price: US$95.57 average (US$95.21 to US$97.10)
Value: US$717K
Holding after: 97,994 shares
Trading plan: Yes (Made under a plan set in advance)
Role: Chief Financial Officer

The filing in full

Date	Security	Transaction	Shares	Price	Holding after	Ownership
Aug 3, 2026	Common Stock	Option exercise	7,500	US$14.50	105,494	Direct
Aug 3, 2026	Common Stock	Sale	5,100	US$95.21	100,394	Direct
Aug 3, 2026	Common Stock	Sale	2,300	US$96.30	98,094	Direct
Aug 3, 2026	Common Stock	Sale	100	US$97.10	97,994	Direct

Source

View original at SEC

Related